CAROLINA Reassures on CV Safety for Linagliptin, Glimepiride in T2D CAROLINA Reassures on CV Safety for Linagliptin, Glimepiride in T2D

"We think we ' ve vindicated sulfonylureas, at least glimepiride specifically," says an expert, who notes trial findings do inform decision-making, particularly when cost is an issue.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news